As of May 27
| +0.55 / +1.27%|
The 5 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 45.00, with a high estimate of 47.00 and a low estimate of 40.00. The median estimate represents a +2.97% increase from the last price of 43.70.
The current consensus among 6 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.